Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.88 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.67 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | MPL | P40238 | 2/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.54 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | RARB | P10826 | 4/20 | 0.52 |
| ▸ | RARA | P10276 | 1/20 | 0.52 |
| ▸ | RARG | P13631 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | IAPP | P10997 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7797217 | 0.95 | PPARA (0.97) | PPARAKAT8PPARGLCKRARB | |
| SCHEMBL1129537 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL2321733 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL6536614 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL27616246 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL1129595 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL1129784 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL10673029 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL1410083 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA | |
| SCHEMBL28045050 | 0.93 | PPARA (1.00) | PPARAKAT8PPARGRARBRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591637-A | Compound with aryl amide structure and medical application thereof | 南京芩领医药科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-108329746-B | Compounds for reducing background color in color change compositions | 西甘产业股份有限公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-108699493-B | Detergent composition | 狮王株式会社 | 2021-10-08 | — | — | CN | disclosed |
| CN-113169351-A | Resin composition for redox flow battery membrane, method for producing redox flow battery membrane using same, and redox flow battery membrane | 乐天化学株式会社 | 2021-07-23 | — | — | CN | disclosed |
| US-10466604-B2 | Electrophotographic photoconductor, image forming apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2019-11-05 | — | — | US | disclosed |
| US-20190011845-A1 | ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE | RICOH COMPANY, LTD. (JP) | 2019-01-10 | — | — | US | disclosed |
| EP-3057578-A1 | COMPOSITION FOR THE ORAL ADMINISTRATION OF CURCUMIN | BRIU GmbH (DE) | 2016-08-24 | — | — | EP | disclosed |
| WO-2015055193-A1 | COMPOSITION FOR THE ORAL ADMINISTRATION OF CURCUMIN | BRIU GMBH (DE) | 2015-04-23 | — | — | WO | disclosed |
| EP-1871844-B1 | BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2014-08-27 | — | — | EP | disclosed |
| EP-1871844-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C Technologies LLC (US) | 2008-01-02 | — | — | EP | disclosed |
| US-20060236470-A1 | Novelty compositions with color changing indicator | CRAYOLA LLC | 2006-10-26 | — | — | US | disclosed |
| WO-2006105193-A2 | PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105261-A1 | CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105260-A1 | ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105191-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060222675-A1 | Personal care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| US-20060222601-A1 | Oral care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| EP-0570230-B1 | External preparation for skin | SHISEIDO CO LTD (JP) | 1998-09-30 | — | — | EP | disclosed |
| US-5580549-A | BLEACHING; 2-HYDROXYBENZOIC ACID COMPOUND | SHISEIDO CO., LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
| EP-0570230-A1 | External preparation for skin | SHISEIDO COMPANY LIMITED (JP) | 1993-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060222675-A1 | Personal care compositions with color changing indicator | CUTA, POLR1C, TYR | PPARA 505/4885KAT8 1768/4885PPARG 107/4885 |
| US-20060222601-A1 | Oral care compositions with color changing indicator | CA9, CA7, TAS2R7 | PPARA 1273/4885KAT8 715/4885PPARG 833/4885 |
| US-20060236470-A1 | Novelty compositions with color changing indicator | MITF, CRABP2, SHH | PPARA 1858/4885KAT8 318/4885PPARG 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.